Circulating tumor cell (CTC) number as a response endpoint in metastatic castration resistant (mCRPC) compared with PSA across five randomized phase 3 trials Meeting Abstract
| Authors: | Heller, G.; McCornnack, R. T.; Kheoh, T.; Smith, M. R.; Dreicer, R.; Saad, F.; De Wit, R.; Aftab, D. T.; Hirmand, M.; MacLean, D. B.; Fizazi, K.; De Bono, J. S.; Scher, H. I. |
| Abstract Title: | Circulating tumor cell (CTC) number as a response endpoint in metastatic castration resistant (mCRPC) compared with PSA across five randomized phase 3 trials |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 264s |
| Language: | English |
| ACCESSION: | WOS:000411931702185 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.5007 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5007 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
